2022 NORTHERN IRELAND ASSEMBLY ELECTION CANDIDATES COMMUNITY PHARMACY VISITS
As part of CPNI public affairs strategy we have been engaging with election candidates, namely deputy and party leaders inviting these political representatives to visit their local community pharmacy to find out more about the valuable role the network plays.
These meeting have been hugely positive and shared on the candidates social media channels, these can be viewed using the links below. To date community pharmacy contractors have hosted the following visits:
Meetings with Naomi Long MLA (ALP) and Clare Bailey MLA (GPNI) are also planned.
I trust this update is helpful. Please do not hesitate to contact CPNI offices should you require any additional information.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Colleague
2021/22 £8m ADHERENCE SUPPORT PAYMENT
Further to Contractor Update I write to confirm that BSO will be allocating the 2021/22 £8m Adherence funding to Contractors in the BSO payment(s) that you will receive on 29 April 2022.
This additional payment will be identifiable in the Adjustments section of your BSO payment report(s) under the heading ‘Additional Adherence Support 2021/22’.
CPNI continues to work with SPPG colleagues to develop the interim service for Adherence support services for new patients being referred by Trust Pharmacists to their Community Pharmacy when the patient is being discharged. Further information will be provided to you once the interim service model is finalised. You are not expected to take on new patients until this interim service is finalised.
DEFERRAL IN THE REPAYMENT OF THE £35m ADVANCE FOR 3 MONTHS
SPPG has confirmed that the repayment of the £35m Advance will be paused for 3 months. No reclaim will be applied to your BSO payments in the months of April, May and June 2022.
CPNI continues to liaise with SPPG in relation to the arrangements that will apply thereafter.
I trust this update is helpful. Please do not hesitate to contact CPNI offices should you require any additional information.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Contractor
The Public Health Agency has oversight of the COVID-19 Vaccination programme in Northern Ireland and has requested that SPPG provide sufficient information to assure that all 477 RQIA registered Care Homes are paired with respective CPVS pharmacies to achieve the successful completion of the Spring COVID-19 Booster Campaign by end of May 2022.
The recent Update G12 outlined the request for the network of Moderna CPVS pharmacies to complete an e-form for each care home requiring to be vaccinated, on a weekly basis each Wednesday.
This is a REMINDER to submit an individual e-form for all of the Care Homes you have made arrangements with, to deliver vaccination clinics. Please complete e-form submissions TODAY.
From 21 April 2022, SPPG would ask that you complete the e-form as soon as you have made a pairing arrangement with a Care Home.
Please do not hesitate to contact CPNI should you require any further information.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
This update contains important information for community pharmacy teams, including details of the ongoing response to the COVID-19 pandemic.
SENT ON BEHALF OF DR. GARETH C. GILVARY Governance & Support Pharmacist
Dear Contractor
Testing for COVID-19 and contact tracing in Northern Ireland is changing. The changes will come into effect from this evening of Friday 22 April 2022.
As signalled in the Department of Health (NI) Transition Plan, these changes are proportionate and necessary at this stage of the pandemic and will deliver a more targeted approach to test and trace, focusing on protecting those at higher risk of serious illness from COVID-19.
Further details can be found HERE. Updated guidance in relation to testing and isolation for health and care workers will be issued by the Department of Health (NI) week commencing 25 April 2022.
Please do not hesitate to contact CPNI should you require any further information.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Colleague
The second update of concessionary prices were granted for April 2022:
Drug
Pack Size
Concessionary Price
Amoxicillin 250mg/5ml oral suspension sugar free
100
£1.40
Baclofen 5mg/5ml oral solution sugar free
300
£2.29
Bisacodyl 10mg suppositories
12
£2.49
Chlorpromazine 50mg tablets
28
£10.24
Co-dydramol 10mg/500mg tablets
100
£7.63
Co-dydramol 10mg/500mg tablets
30
£2.29
Co-trimoxazole 80mg/400mg tablets
28
£2.13
Fludrocortisone 100microgram tablets
30
£8.60
Gabapentin 600mg tablets
100
£6.42
Lercanidipine 20mg tablets
28
£8.12
Oxazepam 10mg tablets
28
£3.99
Oxybutynin 5mg tablets
56
£1.45
Paracetamol 500mg soluble tablets
100
£9.80
Paracetamol 500mg soluble tablets
24
£2.35
Pravastatin 10mg tablets
28
£1.03
Pravastatin 20mg tablets
28
£1.25
Pravastatin 40mg tablets
28
£1.42
Rivastigmine 3mg capsules
28
£3.10
Ropinirole 1mg tablets
84
£51.02
Tizanidine 2mg tablets
120
£6.55
Tolterodine 1mg tablets
56
£2.22
Trospium chloride 20mg tablets
60
£6.35
Valsartan 40mg capsules
28
£2.95
Concessionary prices will be paid against the usual code, no additional endorsements are needed.
Concessionary prices may be granted up until the end of the month so CPNI will notify you of any further concessionary prices as and when they are agreed.
Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicine Shortage Reporter. Concessionary prices are also published on the CPNI website.
Kind regards
SENT ON BEHALF OF DR. GARETH C. GILVARY Governance & Support Pharmacist
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.